Literature DB >> 34416829

Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress.

Nicole G Rummel1, D Allan Butterfield1,2.   

Abstract

Significance: Alzheimer disease (AD) is an all-too-common condition in the aging population. However, aging does not automatically equal neurodegeneration and memory decline. Recent Advances: This review article involves metabolic changes in the AD brain that are related to oxidative stress. Selected pathways are identified as potential targets for intervention in AD. Critical Issues: One of the main factors of AD is the oxidative imbalance within the central nervous system, causing a disruption in metabolic processes. Reactive oxygen species (ROS) are a natural consequence of many cellular processes, especially those associated with mitochondria, such as the electron transport chain. Some ROS, when kept under control and maintained at reasonable levels, often play roles in cell signaling. The cellular damage of ROS arises when oxidative imbalance occurs, in which case ROS are not controlled, leading to a myriad of alterations in cellular metabolic processes. These altered pathways include, among others, dysfunctional glycolysis, calcium regulation, lipid metabolism, mitochondrial processes, and mammalian target of rapamycin pathway dysregulation. Future Directions: Understanding how ROS can lead to these alterations can, ideally, elucidate therapeutic options for retarding AD progression in the aging population. Antioxid. Redox Signal. 36, 1289-1305.

Entities:  

Keywords:  Alzheimer disease; mTORC1; metabolic alterations in AD; oxidative stress

Mesh:

Substances:

Year:  2021        PMID: 34416829      PMCID: PMC9229240          DOI: 10.1089/ars.2021.0177

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   7.468


  138 in total

1.  sAβPPα is a Potent Endogenous Inhibitor of BACE1.

Authors:  Clare Peters-Libeu; Jesus Campagna; Michael Mitsumori; Karen S Poksay; Patricia Spilman; Alex Sabogal; Dale E Bredesen; Varghese John
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 2.  Mitochondria and Calcium in Alzheimer's Disease: From Cell Signaling to Neuronal Cell Death.

Authors:  Maria Calvo-Rodriguez; Brian J Bacskai
Journal:  Trends Neurosci       Date:  2020-11-04       Impact factor: 13.837

3.  Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies.

Authors:  Lisa Mosconi
Journal:  Clin Transl Imaging       Date:  2013-08

4.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

5.  NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency.

Authors:  Yujun Hou; Sofie Lautrup; Stephanie Cordonnier; Yue Wang; Deborah L Croteau; Eduardo Zavala; Yongqing Zhang; Kanako Moritoh; Jennifer F O'Connell; Beverly A Baptiste; Tinna V Stevnsner; Mark P Mattson; Vilhelm A Bohr
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

6.  Evidence of increased oxidative damage in subjects with mild cognitive impairment.

Authors:  J N Keller; F A Schmitt; S W Scheff; Q Ding; Q Chen; D A Butterfield; W R Markesbery
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

7.  Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity.

Authors:  Ralf P Friedrich; Katharina Tepper; Raik Rönicke; Malle Soom; Martin Westermann; Klaus Reymann; Christoph Kaether; Marcus Fändrich
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

8.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease.

Authors:  P Mecocci; U MacGarvey; M F Beal
Journal:  Ann Neurol       Date:  1994-11       Impact factor: 10.422

9.  Reduced hippocampal functional connectivity in Alzheimer disease.

Authors:  Greg Allen; Holly Barnard; Roderick McColl; Andrea L Hester; Julie A Fields; Myron F Weiner; Wendy K Ringe; Anne M Lipton; Matthew Brooker; Elizabeth McDonald; Craig D Rubin; C Munro Cullum
Journal:  Arch Neurol       Date:  2007-10

Review 10.  mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder.

Authors:  M Perluigi; F Di Domenico; E Barone; D A Butterfield
Journal:  Free Radic Biol Med       Date:  2021-04-30       Impact factor: 8.101

View more
  5 in total

Review 1.  Ubiquitin carboxyl-terminal hydrolase L-1 in brain: Focus on its oxidative/nitrosative modification and role in brains of subjects with Alzheimer disease and mild cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2021-11-01       Impact factor: 7.376

Review 2.  Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19.

Authors:  H-F Wei; S Anchipolovsky; R Vera; G Liang; D-M Chuang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2022-03       Impact factor: 3.784

Review 3.  Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases.

Authors:  David Allan Butterfield; Maria Favia; Iolanda Spera; Annalisa Campanella; Martina Lanza; Alessandra Castegna
Journal:  Molecules       Date:  2022-01-30       Impact factor: 4.411

Review 4.  Hormesis and Oxidative Distress: Pathophysiology of Reactive Oxygen Species and the Open Question of Antioxidant Modulation and Supplementation.

Authors:  Mariapaola Nitti; Barbara Marengo; Anna Lisa Furfaro; Maria Adelaide Pronzato; Umberto Maria Marinari; Cinzia Domenicotti; Nicola Traverso
Journal:  Antioxidants (Basel)       Date:  2022-08-19

Review 5.  Neuroimaging Methods to Map In Vivo Changes of OXPHOS and Oxidative Stress in Neurodegenerative Disorders.

Authors:  Jannik Prasuhn; Liesa Kunert; Norbert Brüggemann
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.